{
"NDC": {
"NDCCode": "65597-504-04",
"PackageDescription": "1 BOTTLE in 1 CARTON (65597-504-04) / 14 TABLET, FILM COATED in 1 BOTTLE",
"NDC11Code": "65597-0504-04",
"ProductNDC": "65597-504",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Vanflyta",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Quizartinib",
"DosageFormName": "TABLET, FILM COATED",
"RouteName": "ORAL",
"StartMarketingDate": "20230720",
"EndMarketingDate": null,
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA216993",
"LabelerName": "Daiichi Sankyo Inc.",
"SubstanceName": "QUIZARTINIB DIHYDROCHLORIDE",
"StrengthNumber": "17.7",
"StrengthUnit": "mg/1",
"Pharm_Classes": "FMS-like Receptor Tyrosine Kinase 3 (FLT3) Inhibitors [MoA], Kinase Inhibitor [EPC]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-11-14",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20230720",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}